Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January – June 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Moberg Pharma is continuing to grow at a rapid pace. Product sales in the second quarter of the year rose 107 percent compared with the year-earlier period. In the U.S., sales performed better than expected and, for the first time, our proprietary sales accounted for the majority of revenue.

Help employers find you! Check out all the jobs and post your resume.

Back to news